Header Logo

Barry J Maron MD

TitleAdjunct Professor
InstitutionUMass Chan Medical School
DepartmentMedicine at UMass Chan - Lahey
AddressLahey Hospital and Medical Center
41 Mall Road
Burlington MA 01805
Phone781-825-8650
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentMedicine at UMass Chan - Lahey


    Collapse Biography 
    Collapse education and training
    Occidental College, Los Angeles, CA, United StatesBA
    Tulane University School of Medicine, New Orleans, LA, United StatesMD

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Maron BJ, Casey S, Sengupta JD, Sharkey SW, Maron MS, Rowin EJ. Experience With Extended Follow-Up of?Prophylactically Implanted Defibrillators?for High-Risk Patients With?Hypertrophic?Cardiomyopathy. JACC Adv. 2024 Nov; 3(11):101317. PMID: 39444582.
      Citations:    
    2. Rowin EJ, Das G, Madias C, Hsu M, Crosson L, Turakhia MP, Maron BJ, Maron MS. Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy. Heart Rhythm. 2024 Sep 20. PMID: 39307380.
      Citations:    
    3. Maron MS, Rowin EJ, Maron BJ. Letter by Maron et al Regarding Article, "Sudden Cardiac Death in National Collegiate Athletic Association Athletes". Circulation. 2024 Sep 17; 150(12):e255-e256. PMID: 39283935.
      Citations:    
    4. Harris KM, Mackey-Bojack S, Fisher G, Nwaudo D, Maron BJ. Arrhythmogenic Mitral Valve Prolapse Revisited: A Not Uncommon Cause of Youthful Sudden Death in Athletes and Women. Am J Med. 2024 Aug 13. PMID: 39147083.
      Citations:    
    5. Bonaventura J, Maron BJ. Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations. Int J Cardiol. 2024 Nov 15; 415:132366. PMID: 39025137.
      Citations:    
    6. Aglan A, Fath AR, Maron BJ, Maron MS, Prasad A, Almomani A, Hammadah M, Reynolds MR, Rowin EJ. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 2024 09; 21(9):1677-1683. PMID: 38797308.
      Citations:    
    7. Bonaventura J, Rowin EJ, Chan RH, Chin MT, Puchnerova V, Polakova E, Macek M, Votypka P, Batorsky R, Perera G, Koethe B, Veselka J, Maron BJ, Maron MS. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2024 May 21; 13(10):e033565. PMID: 38757491.
      Citations:    
    8. Abraham S, Rowin EJ, Saji AM, Silver JS, Shekar PS, Maron MS, Maron BJ. Significance and Frequency of Incidental Fortuitous Clinical Identifications of Hypertrophic Cardiomyopathy. JACC Adv. 2024 Jun; 3(6):100948. PMID: 38938870.
      Citations:    
    9. Maron BJ, Maron MS, Rowin EJ. Precision Medicine for All?: What About Hypertrophic Cardiomyopathy? JACC Adv. 2024 May; 3(5):100922. PMID: 38939636.
      Citations:    
    10. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun. 2024 Apr 08; 15(1):3038. PMID: 38589351.
      Citations:    
    11. Narayanan CA, Bokhari N, Rowin EJ, Maron MS, Maron BJ, Link MS, Madias C. Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle-Branch Block After Septal Myectomy. J Am Heart Assoc. 2024 Apr 16; 13(8):e033728. PMID: 38563365.
      Citations:    
    12. Aglan A, Fath AR, Eldaly AS, Anderson AS, Phillips JS, Maron BJ, Maron MS, Rowin EJ. Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Mortality in Hypertrophic Cardiomyopathy. JACC Adv. 2024 Mar; 3(3):100843. PMID: 38938829.
      Citations:    
    13. Rowin EJ, Wadid M, Maron MS, White M, Hook BG, Harnish P, Silver JS, Reynolds MR, Maron BJ. Assessing the impact of atrial fibrillation on symptoms and quality of life in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2024 Apr; 35(4):654-663. PMID: 38288888.
      Citations:    
    14. Maron MS, Rowin EJ, Maron BJ. The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. Am J Cardiol. 2024 02 01; 212S:S64-S76. PMID: 38368038.
      Citations:    
    15. Maron BJ, Rowin EJ, Maron MS. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023. Am J Cardiol. 2024 02 01; 212S:S77-S82. PMID: 38368039.
      Citations:    
    16. Carrick RT, Ahamed H, Sung E, Maron MS, Madias C, Avula V, Studley R, Bao C, Bokhari N, Quintana E, Rajesh-Kannan R, Maron BJ, Wu KC, Rowin EJ. Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach. Heart Rhythm. 2024 08; 21(8):1390-1397. PMID: 38280624.
      Citations:    
    17. Rowin EJ, Link MS, Maron MS, Maron BJ. Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation. 2023 11 28; 148(22):1797-1811. PMID: 38011245.
      Citations:    
    18. Maron BJ, Rowin EJ, Maron MS. Commotio cordis?once again: Unusual occurrence in a noncontact sport. HeartRhythm Case Rep. 2023 Dec; 9(12):855-857. PMID: 38204836.
      Citations:    
    19. Studley R, Madias C, Bokhari N, Carrick RT, Quintana E, Bao C, Maron BJ, Maron MS, Rowin EJ. QRS Fragmentation as a Risk Marker for Sudden Death in Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2023 11; 9(11):2353-2355. PMID: 37632508.
      Citations:    
    20. Maron MS, Mitten M, Borchers J, Rowin EJ, Maron BJ. Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease. J Am Coll Cardiol. 2023 08 29; 82(9):828-832. PMID: 37542484.
      Citations:    
    21. Maron BJ. In Memoriam: WCR: The Remarkable Life and Works of Dr. Bill Roberts. J Am Coll Cardiol. 2023 08 29; 82(9):964-968. PMID: 37516945.
      Citations:    
    22. Maron BJ, Estes NAM, Rowin EJ, Maron MS, Reynolds MR. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023 07 25; 82(4):353-373. PMID: 37468191.
      Citations:    
    23. Maron BJ, Estes NAM. Commotio Cordis Returns?When We Least Expected It: Cardiac Arrest in A Professional Football Player. Am J Cardiol. 2023 09 01; 202:229-232. PMID: 37495440.
      Citations:    
    24. Maron MS, Rowin EJ, Bonaventura J, Maron BJ. Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field? Am J Cardiol. 2023 08 01; 200:236-238. PMID: 37393157.
      Citations:    
    25. Bataiosu R, Hoss S, Scolari FL, Cooper C, Tsoi M, Brahmbhatt DH, Billia F, Lee DZJ, Chan R, Ha ACT, Maron BJ, Rowin E, Maron MS, Ralph-Edwards A, Rakowski H, Adler A. Clinical Significance of Postoperative Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients Undergoing Septal Myectomy. Can J Cardiol. 2023 12; 39(12):1931-1937. PMID: 37355230.
      Citations:    
    26. Bonaventura J, Maron BJ, Berul CI, Rowin EJ, Maron MS. Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity. Heart Rhythm O2. 2023 Aug; 4(8):506-516. PMID: 37645261.
      Citations:    
    27. Bonaventura J, Rowin EJ, Maron MS, Maron BJ. Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease? J Am Heart Assoc. 2023 06 20; 12(12):e028974. PMID: 37301765.
      Citations:    
    28. Maurizi N, Olivotto I, Maron MS, Bonacchi G, Antiochos P, Tomberli B, Fumagalli C, Poggesi C, Berteotti M, Girolami F, Cecchi F, Maron BJ. Lifetime Clinical Course of Hypertrophic?Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades. JACC Adv. 2023 Jun; 2(4):100337. PMID: 38938243.
      Citations:    
    29. Wang RS, Rowin EJ, Maron BJ, Maron MS, Maron BA. A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification. Cardiovasc Res. 2023 05 02; 119(3):e125-e127. PMID: 37129987.
      Citations:    
    30. Maron BJ, Cooper S, Sheppard MN. Erratum to 'Defining Commotio Cordis': The American Journal of Cardiology Volume 124, Issue 10,?15 November 2019, Pages 1649-1650. Am J Cardiol. 2023 Apr 15; 193:133. PMID: 37003669.
      Citations:    
    31. Massera D, Sherrid MV, Maron MS, Rowin EJ, Maron BJ. How common is hypertrophic cardiomyopathy? really?: Disease prevalence revisited 27?years after CARDIA. Int J Cardiol. 2023 07 01; 382:64-67. PMID: 37028711.
      Citations:    
    32. Maron MS, Rowin E, Spirito P, Maron BJ. Differing strategies for sudden death prevention in hypertrophic cardiomyopathy. Heart. 2023 03 27; 109(8):589-594. PMID: 36270782.
      Citations:    
    33. Maron BJ, Rowin EJ, Ambe SP, Maron MS. The Reply. Am J Med. 2023 03; 136(3):e50. PMID: 36796956.
      Citations:    
    34. Bonaventura J, Rowin EJ, Maron MS, Maron BJ. Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players. Am J Med. 2023 03; 136(3):315-321. PMID: 36495934.
      Citations:    
    35. Rowin EJ, Ruberg FL, Das G, Higgins D, Lipe WC, Bokhari N, Dehn M, Maron BJ, Maron MS. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2022 12; 15(12):e014938. PMID: 36448453.
      Citations:    
    36. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun. 2022 Nov 17; 13(1):7026. PMID: 36396654.
      Citations:    
    37. Maron BA, Kleiner DE, Arons E, Wertheim BM, Sharma NS, Haley KJ, Samokhin AO, Rowin EJ, Maron MS, Rosing DR, Maron BJ. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension. Chest. 2023 03; 163(3):678-686. PMID: 36243062.
      Citations:    
    38. Abdelfattah OM, Martinez M, Sayed A, ElRefaei M, Abushouk AI, Hassan A, Masri A, Winters SL, Kapadia SR, Maron BJ, Rowin E, Maron MS. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2022 11; 8(11):1417-1427. PMID: 36424010.
      Citations:    
    39. Maron BJ, Maron MS, Sherrid MV, Ommen SR, Rowin EJ. Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine. Am J Cardiol. 2022 11 15; 183:150-152. PMID: 36114018.
      Citations:    
    40. Maron BJ, Dearani JA, Smedira NG, Schaff HV, Wang S, Rastegar H, Ralph-Edwards A, Ferrazzi P, Swistel D, Shemin RJ, Quintana E, Bannon PG, Shekar PS, Desai M, Roberts WC, Lever HM, Adler A, Rakowski H, Spirito P, Nishimura RA, Ommen SR, Sherrid MV, Rowin EJ, Maron MS. Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel. Am J Cardiol. 2022 10 01; 180:124-139. PMID: 35965115.
      Citations:    
    41. Maron BA, Wang RS, Carnethon MR, Rowin EJ, Loscalzo J, Maron BJ, Maron MS. What Causes Hypertrophic Cardiomyopathy? Am J Cardiol. 2022 09 15; 179:74-82. PMID: 35843734.
      Citations:    
    42. Rowin EJ, Cooper C, Carrick RT, Tsoi M, Maron BJ, Maron MS. Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2022 09 15; 179:70-73. PMID: 35835601.
      Citations:    
    43. Maron BJ, Maron MS. Jeff Zucker Says Hypertrophic Cardiomyopathy is a Curable Disease: A Patient's Perspective. Am J Cardiol. 2022 06 01; 172:154-156. PMID: 35569883.
      Citations:    
    44. Maron BJ, Maron MS. Reflections on Six Decades of Hypertrophic Cardiomyopathy From Eugene Braunwald. Am J Cardiol. 2022 06 01; 172:150-153. PMID: 35569882.
      Citations:    
    45. Maron MS, Lanuario EL, Rowin EJ, Maron BJ. Global Dissemination and Implementation of Contemporary Management Principles for Hypertrophic Cardiomyopathy and Role of the International HCM Summit. Am J Cardiol. 2022 06 01; 172:146-149. PMID: 35569881.
      Citations:    
    46. Maron BJ, Rowin EJ, Ambe SP, Maron MS. Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical Research. Am J Med. 2022 10; 135(10):1244-1246. PMID: 35649468.
      Citations:    
    47. Maron BJ, Maron MS, Sherrid MV, Rowin EJ. Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2022 05 03; 11(9):e024566. PMID: 35502772.
      Citations:    
    48. Cui H, Schaff HV, Wang S, Lahr BD, Rowin EJ, Rastegar H, Hu S, Eleid MF, Dearani JA, Kimmelstiel C, Maron BJ, Nishimura RA, Ommen SR, Maron MS. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients?With Obstructive Hypertrophic?Cardiomyopathy. J Am Coll Cardiol. 2022 05 03; 79(17):1647-1655. PMID: 35483751.
      Citations:    
    49. Maron MS, Rosing DR, Braunwald E, Rastegar H, Koethe B, Roberts WC, Maron BJ, Rowin EJ. Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to Present. Am J Cardiol. 2022 06 01; 172:107-108. PMID: 35361474.
      Citations:    
    50. Larson A, Codden CJ, Huggins GS, Rastegar H, Chen FY, Maron BJ, Rowin EJ, Maron MS, Chin MT. Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy. Sci Rep. 2022 03 25; 12(1):5211. PMID: 35338173.
      Citations:    
    51. Maron BJ, Rowin EJ, Madias C, Dolan N, Maron MS. Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far). Am J Cardiol. 2022 04 01; 168:163-165. PMID: 35131099.
      Citations:    
    52. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Dearani JA, Rowin EJ, Maron MS, Sherrid MV. Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 02 01; 79(4):390-414. PMID: 35086661.
      Citations:    
    53. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Diagnosis and Evaluation of Hypertrophic?Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 02 01; 79(4):372-389. PMID: 35086660.
      Citations:    
    54. Maron BJ, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy: New Concepts and Therapies. Annu Rev Med. 2022 01 27; 73:363-375. PMID: 35084989.
      Citations:    
    55. Maron MS, Rowin EJ, Maron BJ. Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten? Asian Cardiovasc Thorac Ann. 2022 Jan; 30(1):11-18. PMID: 35068194.
      Citations:    
    56. Rowin EJ, Maron MS, Adler A, Albano AJ, Varnava AM, Spears D, Marsy D, Heitner SB, Cohen E, Leong KMW, Winters SL, Martinez MW, Koethe BC, Rakowski H, Maron BJ. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study. Heart Rhythm. 2022 05; 19(5):782-789. PMID: 34933112.
      Citations:    
    57. Sridharan A, Maron MS, Carrick RT, Madias CA, Huang D, Cooper C, Drummond J, Maron BJ, Rowin EJ. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2022 01; 33(1):20-29. PMID: 34845799.
      Citations:    
    58. Maron MS, Rastegar H, Dolan N, Carpino P, Koethe B, Maron BJ, Rowin EJ. Outcomes Over Follow-up =10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2022 01 15; 163:91-97. PMID: 34785034.
      Citations:    
    59. Sherrid MV, Swistel DG, Olivotto I, Pieroni M, Wever-Pinzon O, Riedy K, Bach RG, Husaini M, Cresci S, Reyentovich A, Massera D, Maron MS, Maron BJ, Kim B. Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2021 10 19; 10(20):e021141. PMID: 34634917.
      Citations:    
    60. Maron BJ, Maron MS, Maurer MS, Rowin EJ, Maron BA, Gali? N. Cardiovascular Diseases That Have Emerged From the Darkness. J Am Heart Assoc. 2021 10 19; 10(20):e021095. PMID: 34622668.
      Citations:    
    61. Udelson JE, Rowin EJ, Maron BJ. Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear. JAMA Cardiol. 2021 09 01; 6(9):997-999. PMID: 34042956.
      Citations:    
    62. Alcalai R, Arad M, Wakimoto H, Yadin D, Gorham J, Wang L, Burns E, Maron BJ, Roberts WC, Konno T, Conner DA, Perez-Atayde AR, Seidman JG, Seidman CE. LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart. J Am Heart Assoc. 2021 09 07; 10(17):e018829. PMID: 34459252.
      Citations:    
    63. Maron BJ, Link MS. Don't Forget Commotio Cordis. Am J Cardiol. 2021 10 01; 156:134-135. PMID: 34304863.
      Citations:    
    64. Rowin EJ, Maron BJ, Wells S, Burrows A, Firely C, Koethe B, Patel AR, Maron MS. Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2021 07 15; 151:86-92. PMID: 34167691.
      Citations:    
    65. Carrick RT, Maron MS, Adler A, Wessler B, Hoss S, Chan RH, Sridharan A, Huang D, Cooper C, Drummond J, Rakowski H, Maron BJ, Rowin EJ. Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score. Circ Arrhythm Electrophysiol. 2021 06; 14(6):e009796. PMID: 34129346.
      Citations:    
    66. Papanastasiou CA, Zegkos T, Karamitsos TD, Rowin EJ, Maron MS, Parcharidou D, Kokkinidis DG, Karvounis H, Rimoldi O, Maron BJ, Efthimiadis GK. Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis. Int J Cardiol. 2021 06 01; 332:127-132. PMID: 33794232.
      Citations:    
    67. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J. Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun. 2021 02 08; 12(1):873. PMID: 33558530.
      Citations:    
    68. Maron BJ, Rowin EJ, Maron MS. Is Regression of Left Ventricular Hypertrophy Really a Good Thing for Patients With Hypertrophic Cardiomyopathy?: The Emerging Mavacamten Story. Am J Cardiol. 2021 05 15; 147:145-146. PMID: 33549527.
      Citations:    
    69. Maron BJ, Rowin EJ, Maron MS. Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator. Heart Rhythm. 2021 06; 18(6):1012-1023. PMID: 33508516.
      Citations:    
    70. Maron BJ, Rowin EJ, Maron MS. Erratum to "Hypertrophic Cardiomyopathy: Is a 'Cure' Coming ? Or Is It Already Here?": American Journal of Medicine, 133 (2020):8:886-888. Am J Med. 2021 Mar; 134(3):412. PMID: 33419521.
      Citations:    
    71. Harris KM, Mackey-Bojack S, Bennett M, Nwaudo D, Duncanson E, Maron BJ. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am J Cardiol. 2021 03 15; 143:131-134. PMID: 33347841.
      Citations:    
    72. Maron BJ, Rowin EJ, Maron MS. After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease With Low Mortality and Morbidity, But is This Paradigm Under-Recognized in the Literature? Am J Cardiol. 2021 03 01; 142:136-137. PMID: 33309776.
      Citations:    
    73. Shirani J, Aurshiya R, Elshaikh A, Olenchock SA, Rowin EJ, Maron MS, Maron BJ. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices. Am J Cardiol. 2021 03 01; 142:130-135. PMID: 33279482.
      Citations:    
    74. Maron MS, Rowin EJ, Maron BJ. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: the newest high-risk phenotype. Eur Heart J Cardiovasc Imaging. 2020 12 01; 21(12):1351-1352. PMID: 33245756.
      Citations:    
    75. Habib M, Adler A, Fardfini K, Hoss S, Hanneman K, Rowin EJ, Maron MS, Maron BJ, Rakowski H, Chan RH. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study. JACC Cardiovasc Imaging. 2021 05; 14(5):947-958. PMID: 33248971.
      Citations:    
    76. Maron BJ, Estes NAM. The "Guidant Affair": 15 years later. Heart Rhythm. 2021 03; 18(3):487-488. PMID: 33250366.
      Citations:    
    77. Rowin EJ, Burrows A, Madias C, Estes NAM, Link MS, Maron MS, Maron BJ. Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants. Circ Arrhythm Electrophysiol. 2020 10; 13(10):e008123. PMID: 32897759.
      Citations:    
    78. Rowin EJ, Maron BJ, Maron MS. Reply: The LVAD in the Management of Advanced Heart?Failure Due to Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2020 10 20; 76(16):1913. PMID: 32805353.
      Citations:    
    79. Maron BJ, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here? Am J Med. 2020 08; 133(8):886-888. PMID: 32741446.
      Citations:    
    80. Maron MS, Steiger N, Burrows A, Madias C, Weinstock J, Link MS, Rowin EJ, Maron BJ. Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2020 08; 6(8):1019-1021. PMID: 32819515.
      Citations:    
    81. Maron MS, Brush J, Rowin EJ, Maron BJ. Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoring. Heart Rhythm. 2021 01; 18(1):148-150. PMID: 32717313.
      Citations:    
    82. Maron BJ, Maron MS. PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light. J Am Coll Cardiol. 2020 07 14; 76(2):198-200. PMID: 32646570.
      Citations:    
    83. Rowin EJ, Maron BJ, Carrick RT, Patel PP, Koethe B, Wells S, Maron MS. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2020 06 23; 75(24):3033-3043. PMID: 32553256.
      Citations:    
    84. Rowin EJ, Sridharan A, Madias C, Firely C, Koethe B, Link MS, Maron MS, Maron BJ. Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 08 01; 128:75-83. PMID: 32650928.
      Citations:    
    85. Maron BJ, Mackey-Bojack S, Facile E, Duncanson E, Rowin EJ, Maron MS. Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy. Am J Cardiol. 2020 07 15; 127:139-141. PMID: 32375998.
      Citations:    
    86. Maron BJ, Rowin EJ, Arkun K, Rastegar H, Larson AM, Maron MS, Chin MT. Adult Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Disease Expression and Clinical Course. Am J Cardiol. 2020 07 15; 127:135-138. PMID: 32430163.
      Citations:    
    87. Adalsteinsdottir B, Burke M, Maron BJ, Danielsen R, Lopez B, Diez J, Jarolim P, Seidman J, Seidman CE, Ho CY, Gunnarsson GT. Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers. Open Heart. 2020; 7(1):e001220. PMID: 32341788.
      Citations:    
    88. Kumar KR, Mandleywala SN, Madias C, Weinstock J, Rowin EJ, Maron BJ, Maron MS, Link MS. Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 06 15; 125(12):1896-1900. PMID: 32305220.
      Citations:    
    89. Sherrid MV, Riedy K, Rosenzweig B, Massera D, Saric M, Swistel DG, Ahluwalia M, Arabadjian M, DeFonte M, Stepanovic A, Serrato S, Xia Y, Zhong H, Maron MS, Maron BJ, Reynolds HR. Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome. Am J Cardiol. 2020 06 01; 125(11):1700-1709. PMID: 32278461.
      Citations:    
    90. Maron BJ, Rowin EJ, Maron MS. Concerns About the HCM Risk-Kids Study. JAMA Cardiol. 2020 03 01; 5(3):362-363. PMID: 31995123.
      Citations:    
    91. Rowin EJ, Maron MS, Bhatt V, Gillam L, Maron BJ. Hypertrophic Cardiomyopathy in "Real-World" Community Cardiology Practice. Am J Cardiol. 2020 05 01; 125(9):1398-1403. PMID: 32151436.
      Citations:    
    92. Maron MS, Rowin EJ, Maron BJ. Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy? Trends Cardiovasc Med. 2021 01; 31(1):32-33. PMID: 31883862.
      Citations:    
    93. Rowin EJ, Maron BJ, Maron MS. The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism?of?Multimodality Imaging: Clinical and Etiologic Implications. JACC Cardiovasc Imaging. 2020 09; 13(9):2002-2016. PMID: 31864978.
      Citations:    
    94. Sharkey SW, Henry TD, Maron BJ. Response: How common is comorbid takotsubo syndrome in patients with acute coronary syndromes? Catheter Cardiovasc Interv. 2020 09 01; 96(3):727. PMID: 31854099.
      Citations:    
    95. Sharkey SW, Kalra A, Henry TD, Smith TD, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ. Coexistence of acute takotsubo syndrome and acute coronary syndrome. Catheter Cardiovasc Interv. 2020 10 01; 96(4):825-829. PMID: 31696663.
      Citations:    
    96. Rowin EJ, Maron MS, Wells S, Patel PP, Koethe BC, Maron BJ. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2019 11 05; 8(21):e012041. PMID: 31663408.
      Citations:    
    97. Boll G, Rowin EJ, Maron BJ, Wang W, Rastegar H, Maron MS. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 01 01; 125(1):120-126. PMID: 31727261.
      Citations:    
    98. Maron BJ, Harris KM, Maron MS. The Guidant Affair revisited?but this time with good news. Heart Rhythm. 2020 03; 17(3):512-513. PMID: 31593780.
      Citations:    
    99. Maron M, Rowin E, Maron BJ. Increasing evidence that risk scores underperform in predicting sudden death in hypertrophic cardiomyopathy. Heart. 2019 12; 105(24):1850-1851. PMID: 31551293.
      Citations:    
    100. Maron BJ, Sheppard CS. Defining Commotio Cordis. Am J Cardiol. 2019 11 15; 124(10):1649-1650. PMID: 31537298.
      Citations:    
    101. Maron BJ, Rowin EJ, Maron MS. Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. Circ Res. 2019 08 02; 125(4):370-378. PMID: 31518168.
      Citations:    
    102. Kimmelstiel C, Zisa DC, Kuttab JS, Wells S, Udelson JE, Wessler BS, Rastegar H, Kapur NK, Weintraub AR, Maron BJ, Maron MS, Rowin EJ. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes. Circ Cardiovasc Interv. 2019 07; 12(7):e007673. PMID: 31296080.
      Citations:    
    103. Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019 07 01; 4(7):644-657. PMID: 31116360.
      Citations:    
    104. Maron MS, Rowin EJ, Maron BJ. The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps Specificity. Can J Cardiol. 2019 12; 35(12):1626-1628. PMID: 31703825.
      Citations:    
    105. Thiene G, Rizzo S, Schiavon M, Maron MS, Zorzi A, Corrado D, Maron BJ, Basso C. Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People. J Am Coll Cardiol. 2019 06 18; 73(23):3031-3032. PMID: 31196462.
      Citations:    
    106. Cooper S, Woodford NW, Maron BJ, Harris KM, Sheppard MN. A Lethal Blow to the Chest as an Underdiagnosed Cause of Sudden Death in United Kingdom Sports (Football, Cricket, Rugby). Am J Cardiol. 2019 09 01; 124(5):808-811. PMID: 31277792.
      Citations:    
    107. Rowin EJ, Romashko M, Testani JM, Koethe BC, Saxena D, Udelson JE, Maron BJ, Maron MS. Chronic Heart Failure Is Infrequently Associated With Renal Dysfunction in Hypertrophic Cardiomyopathy. J Card Fail. 2019 08; 25(8):690-692. PMID: 31158468.
      Citations:    
    108. Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving Beyond the Sarcomere to Explain?Heterogeneity in Hypertrophic?Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 04 23; 73(15):1978-1986. PMID: 31000001.
      Citations:    
    109. Rowin EJ, Maron BJ, Romashko M, Wang W, Rastegar H, Link MS, Maron MS. Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy. Am J Cardiol. 2019 07 01; 124(1):113-121. PMID: 31027655.
      Citations:    
    110. Maron BJ, Rowin EJ, Maron MS. Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)". Circulation. 2019 03 19; 139(12):1557-1558. PMID: 30883223.
      Citations:    
    111. Miller CAS, Maron MS, Estes NAM, Price LL, Rowin EJ, Maron BJ, Link MS. Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Am J Cardiol. 2019 06 01; 123(11):1859-1862. PMID: 30922542.
      Citations:    
    112. Maurizi N, Michels M, Rowin EJ, Semsarian C, Girolami F, Tomberli B, Cecchi F, Maron MS, Olivotto I, Maron BJ. Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy. Circulation. 2019 02 05; 139(6):830-833. PMID: 30715937.
      Citations:    
    113. Rowin EJ, Mohanty S, Madias C, Maron BJ, Maron MS. Benefit of Cardiac Resynchronization Therapy in End-Stage Nonobstructive Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2019 01; 5(1):131-133. PMID: 30678779.
      Citations:    
    114. Maron MS, Spirito P, Maron BJ. Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy. Circulation. 2018 11 06; 138(19):2076-2078. PMID: 30474424.
      Citations:    
    115. Maron BJ, Thompson PD. Longevity in elite athletes: the first 4-min milers. Lancet. 2018 09 15; 392(10151):913. PMID: 30238881.
      Citations:    
    116. Maron MS, Udelson JE, Rowin EJ, Maron BJ. Reply: Atrial Fibrillation in Hypertrophic Cardiomyopathy. JACC Heart Fail. 2018 09; 6(9):807-808. PMID: 30166029.
      Citations:    
    117. Madias C, Maron BJ, Dau N, Estes NAM, Bir C, Link MS. Size as an Important Determinant of Chest Blow-induced Commotio Cordis. Med Sci Sports Exerc. 2018 09; 50(9):1767-1771. PMID: 29620687.
      Citations:    
    118. Sharkey SW, Maron BJ, Kloner RA. The Case for Takotsubo Cardiomyopathy (Syndrome) as a Variant of Acute Myocardial Infarction. Circulation. 2018 08 28; 138(9):855-857. PMID: 30354447.
      Citations:    
    119. Sharkey SW, Maron BJ. Survival After Takotsubo, Revisited. J Am Coll Cardiol. 2018 08 21; 72(8):883-884. PMID: 30115227.
      Citations:    
    120. Maron BJ. Clinical Course and Management of Hypertrophic Cardiomyopathy. N Engl J Med. 2018 Aug 16; 379(7):655-668. PMID: 30110588.
      Citations:    
    121. Rowin EJ, Maron BJ, Chokshi A, Kannappan M, Arkun K, Wang W, Rastegar H, Maron MS. Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 10 15; 122(8):1409-1420. PMID: 30107902.
      Citations:    
    122. Maron BJ, Maron MS. Summary of Presentations and Discussions of Hypertrophic Cardiomyopathy at the 2018 Boston International Summit VI Including Consensus, Controversies, and Unmet Needs. Am J Cardiol. 2018 10 01; 122(7):1281-1286. PMID: 30173818.
      Citations:    
    123. Rowin EJ, Maron BJ, Chokshi A, Maron MS. Left?ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any age. Pacing Clin Electrophysiol. 2018 Jun 12. PMID: 29893504.
      Citations:    
    124. Rowin EJ, Maron MS, Maron BJ. Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy". Circulation. 2018 06 05; 137(23):2541-2542. PMID: 29866781.
      Citations:    
    125. Harris KM, Creswell LL, Maron BJ. Death and Cardiac Arrest in U.S. Triathlon Participants. Ann Intern Med. 2018 05 15; 168(10):753. PMID: 29800442.
      Citations:    
    126. Wells S, Rowin EJ, Bhatt V, Maron MS, Maron BJ. Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy. Circulation. 2018 05 01; 137(18):1973-1975. PMID: 29712699.
      Citations:    
    127. Maron BJ, Rowin EJ, Maron MS. Global Burden of Hypertrophic?Cardiomyopathy. JACC Heart Fail. 2018 05; 6(5):376-378. PMID: 29724362.
      Citations:    
    128. Maron BJ, Rowin EJ, Udelson JE, Maron MS. Clinical Spectrum and Management?of?Heart Failure in?Hypertrophic?Cardiomyopathy. JACC Heart Fail. 2018 05; 6(5):353-363. PMID: 29655822.
      Citations:    
    129. Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, Ahmed A, Boriani G, Francia P, Winters SL, Giudici M, Koulova A, Garberich R, Rowin EJ, Sears SF, Maron MS, Spirito P. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol. 2018 04; 11(4):e005820. PMID: 29625970.
      Citations:    
    130. Maron MS, Chan RH, Kapur NK, Jaffe IZ, McGraw AP, Kerur R, Maron BJ, Udelson JE. Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy. Am J Med. 2018 07; 131(7):837-841. PMID: 29604289.
      Citations:    
    131. Solomon Z, Breton C, Rowin EJ, Maron BJ, Maron MS, Chen FY, Rastegar H. Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy. Semin Thorac Cardiovasc Surg. 2018; 30(2):125-128. PMID: 29524602.
      Citations:    
    132. Maron BJ, Estes NAM, Maron MS. Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field? Am J Cardiol. 2018 04 15; 121(8):1008-1010. PMID: 29472006.
      Citations:    
    133. Rowin EJ, Maron BJ, Abt P, Kiernan MS, Vest A, Costantino F, Maron MS, DeNofrio D. Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 04 15; 121(8):986-996. PMID: 29496192.
      Citations: 13     Fields:    Translation:Humans
    134. Wells S, Rowin EJ, Boll G, Rastegar H, Wang W, Maron MS, Maron BJ. Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy. Am J Med. 2018 06; 131(6):e235-e239. PMID: 29353047.
      Citations:    
    135. Estes NAM, Maron BJ. Defibrillation threshold testing in hypertrophic cardiomyopathy: As SIMPLE as possible but not simpler. Heart Rhythm. 2018 03; 15(3):393-394. PMID: 29229517.
      Citations:    
    136. Rowin EJ, Maron BJ, Olivotto I, Maron MS. Role of Exercise Testing in Hypertrophic?Cardiomyopathy. JACC Cardiovasc Imaging. 2017 11; 10(11):1374-1386. PMID: 29122139.
      Citations:    
    137. Maron BJ. Harvey Feigenbaum, MD, and the Creation of Clinical Echocardiography: A Conversation With Barry J. Maron, MD. Am J Cardiol. 2017 12 01; 120(11):2085-2099. PMID: 29156174.
      Citations:    
    138. Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, Desnick RJ, Maron BJ. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy. Am J Med. 2018 02; 131(2):200.e1-200.e8. PMID: 28943383.
      Citations:    
    139. Rowin EJ, Maron MS, Chan RH, Hausvater A, Wang W, Rastegar H, Maron BJ. Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Dec 15; 120(12):2256-2264. PMID: 29111210.
      Citations:    
    140. Harris KM, Creswell LL, Haas TS, Thomas T, Tung M, Isaacson E, Garberich RF, Maron BJ. Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series. Ann Intern Med. 2017 Oct 17; 167(8):529-535. PMID: 28975231.
      Citations:    
    141. Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM, Maron MS, Maron BJ. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation. 2017 Dec 19; 136(25):2420-2436. PMID: 28916640.
      Citations:    
    142. McKenna WJ, Maron BJ, Thiene G. Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circ Res. 2017 Sep 15; 121(7):722-730. PMID: 28912179.
      Citations:    
    143. Rowin EJ, Maron BJ, Arkun K, Maron MS. Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathy. Eur Heart J. 2017 08 14; 38(31):2444. PMID: 28520911.
      Citations:    
    144. Adalsteinsdottir B, Palsson R, Desnick RJ, Gardarsdottir M, Teekakirikul P, Maron M, Appelbaum E, Neisius U, Maron BJ, Burke MA, Chen B, Pagant S, Madsen CV, Danielsen R, Arngrimsson R, Feldt-Rasmussen U, Seidman JG, Seidman CE, Gunnarsson GT. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes. Circ Cardiovasc Genet. 2017 Aug; 10(4). PMID: 28798024.
      Citations:    
    145. Maron BJ, Rowin EJ, Maron MS, Braunwald E. Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is Possible. Am J Med. 2017 Nov; 130(11):1236-1237. PMID: 28760492.
      Citations:    
    146. Rowin EJ, Maron BJ, Maron MS. Reply: Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm. J Am Coll Cardiol. 2017 07 18; 70(3):407. PMID: 28705326.
      Citations:    
    147. Kannappan M, Maron BJ, Rastegar H, Pandian NG, Maron MS, Rowin EJ. Underappreciated occurrence of discrete subaortic membranes producing left ventricular outflow obstruction in hypertrophic cardiomyopathy. Echocardiography. 2017 Aug; 34(8):1247-1249. PMID: 28681495.
      Citations:    
    148. Maron MS, Rowin EJ, Maron BJ. How to Image Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 07; 10(7). PMID: 28701526.
      Citations:    
    149. Rastegar H, Boll G, Rowin EJ, Dolan N, Carroll C, Udelson JE, Wang W, Carpino P, Maron BJ, Maron MS, Chen FY. Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. Ann Cardiothorac Surg. 2017 Jul; 6(4):353-363. PMID: 28944176.
      Citations:    
    150. Spirito P, Rossi J, Maron BJ. Alcohol septal ablation: in which patients and why? Ann Cardiothorac Surg. 2017 Jul; 6(4):369-375. PMID: 28944178.
      Citations:    
    151. Maron BJ, Maron MS, Rowin EJ. Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy. Circulation. 2017 06 13; 135(24):2317-2319. PMID: 28606946.
      Citations:    
    152. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NAM, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Jordaens L, Law I, Loomis M, Willems R, Barth C, Broos K, Brandt C, Dziura J, Li F, Simone L, Vandenberghe K, Cannom D. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. Circulation. 2017 06 06; 135(23):2310-2312. PMID: 28584032.
      Citations:    
    153. Covella M, Rowin EJ, Hill NS, Preston IR, Milan A, Opotowsky AR, Maron BJ, Maron MS, Maron BA. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy. Circ Heart Fail. 2017 Apr; 10(4):e003689. PMID: 28396501.
      Citations:    
    154. Link MS, Bockstall K, Weinstock J, Alsheikh-Ali AA, Semsarian C, Estes NAM, Spirito P, Haas TS, Rowin EJ, Maron MS, Maron BJ. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications. J Cardiovasc Electrophysiol. 2017 May; 28(5):531-537. PMID: 28240435.
      Citations:    
    155. Rowin EJ, Orfanos A, Estes NAM, Wang W, Link MS, Maron MS, Maron BJ. Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 06 01; 119(11):1862-1865. PMID: 28395893.
      Citations:    
    156. Wang W, Lian Z, Rowin EJ, Maron BJ, Maron MS, Link MS. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3). PMID: 28314849.
      Citations:    
    157. Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS. Hypertrophic Cardiomyopathy With Left?Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. J Am Coll Cardiol. 2017 02 21; 69(7):761-773. PMID: 28209216.
      Citations:    
    158. Maron BJ, Dearani JA, Maron MS, Ommen SR, Rastegar H, Nishimura RA, Swistel DG, Sherrid MV, Ralph-Edwards A, Rakowski H, Smedira NG, Rowin EJ, Desai MY, Lever HM, Spirito P, Ferrazzi P, Schaff HV. Why we need more septal myectomy surgeons: An emerging recognition. J Thorac Cardiovasc Surg. 2017 11; 154(5):1681-1685. PMID: 28268009.
      Citations:    
    159. Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (?-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 Feb; 10(2). PMID: 28193612.
      Citations:    
    160. Maron BJ, Nishimura RA, Maron MS. Shared decision-making in HCM. Nat Rev Cardiol. 2017 03; 14(3):125-126. PMID: 28127029.
      Citations:    
    161. Maron BJ, Rowin EJ, Maron MS, Braunwald E. Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored ? Until Now. Am J Med. 2017 02; 130(2):119-123. PMID: 27746287.
      Citations:    
    162. Maron BJ, Maron MS. A Discussion of Contemporary Nomenclature, Diagnosis, Imaging, and Management of Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 12 15; 118(12):1897-1907. PMID: 27863696.
      Citations:    
    163. Maron MS, Maron BJ. Reply: Nonobstructive Hypertrophic Cardiomyopathy: Low Mortality but Not Always Benign. J Am Coll Cardiol. 2016 08 30; 68(9):983. PMID: 27561777.
      Citations:    
    164. Maron BJ, Maron BA. Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle. JACC Cardiovasc Imaging. 2017 04; 10(4):394-397. PMID: 27544897.
      Citations:    
    165. Maron BJ, Maron MS. LGE Means Better Selection of HCM?Patients for Primary Prevention Implantable Defibrillators. JACC Cardiovasc Imaging. 2016 12; 9(12):1403-1406. PMID: 27450875.
      Citations:    
    166. Maron BJ, Maron MS. The Remarkable 50 Years of Imaging in?HCM and How?it Has Changed Diagnosis?and Management: From M-Mode Echocardiography to CMR. JACC Cardiovasc Imaging. 2016 07; 9(7):858-872. PMID: 27388665.
      Citations:    
    167. Maron BJ. Saving Lives One at a Time. JAMA Cardiol. 2016 07 01; 1(4):387-8. PMID: 27438313.
      Citations:    
    168. Maron BJ, Roberts WC. The Father of Septal Myectomy for Obstructive HCM, Who Also Had HCM: The Unbelievable Story. J Am Coll Cardiol. 2016 06 21; 67(24):2900-3. PMID: 27311529.
      Citations:    
    169. Sorajja P, Pedersen WA, Bae R, Lesser JR, Jay D, Lin D, Harris K, Maron BJ. First Experience With Percutaneous?Mitral?Valve Plication as Primary Therapy?for Symptomatic Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2016 06 21; 67(24):2811-8. PMID: 27311518.
      Citations:    
    170. Konstantinou DM, Efthimiadis GK, Vassilikos V, Paraskevaidis S, Pagourelias E, Maron BJ, Karvounis H. Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2016 Jun; 17(6):433-9. PMID: 26885981.
      Citations:    
    171. Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF. Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. Am J Med. 2016 Nov; 129(11):1170-1177. PMID: 27039955.
      Citations:    
    172. Maron BJ, Rowin EJ, Casey SA, Maron MS. How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice. JAMA Cardiol. 2016 04 01; 1(1):98-105. PMID: 27437663.
      Citations:    
    173. Maron MS, Rowin EJ, Olivotto I, Casey SA, Arretini A, Tomberli B, Garberich RF, Link MS, Chan RHM, Lesser JR, Maron BJ. Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2016 Mar 29; 67(12):1399-1409. PMID: 27012399.
      Citations:    
    174. Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ. Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 06 01; 117(11):1808-14. PMID: 27089980.
      Citations:    
    175. Maron MS, Maron BJ. Response to Letter Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy". Circulation. 2016 Mar 01; 133(9):e422. PMID: 26927013.
      Citations:    
    176. Maron BJ, Maron MS. Nonobstructive Hypertrophic Cardiomyopathy: Overlooked But Not Forgotten. Mayo Clin Proc. 2016 Mar; 91(3):277-8. PMID: 26944239.
      Citations:    
    177. Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S. Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes? Am J Cardiol. 2016 Apr 15; 117(8):1339-41. PMID: 26949036.
      Citations:    
    178. Lynge TH, Risgaard B, Jabbari R, Glinge C, Bundgaard H, Maron B, Hauns? S, Winkel BG, Tfelt-Hansen J. Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark. Europace. 2016 Dec; 18(12):1801-1808. PMID: 26823388.
      Citations:    
    179. Maron BJ, Maron MS. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. Heart Rhythm. 2016 05; 13(5):1155-1165. PMID: 26749314.
      Citations:    
    180. Williams LK, Chan RH, Carasso S, Durand M, Misurka J, Crean AM, Ralph-Edwards A, Gruner C, Woo A, Lesser JR, Maron BJ, Maron MS, Rakowski H. Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy. Biomed Res Int. 2015; 2015:481245. PMID: 26788503.
      Citations:    
    181. Maron BJ, Spirito P. Surgical Ventricular Septal Myectomy in the Developing World. Am J Cardiol. 2016 Mar 01; 117(5):874-7. PMID: 26796193.
      Citations:    
    182. Maron BJ, Fox PR. Hypertrophic cardiomyopathy in man and cats. J Vet Cardiol. 2015 Dec; 17 Suppl 1:S6-9. PMID: 26776595.
      Citations:    
    183. Maron BJ, Rowin EJ, Casey SA, Garberich RF, Maron MS. What Do Patients With Hypertrophic Cardiomyopathy Die from? Am J Cardiol. 2016 Feb 01; 117(3):434-5. PMID: 26718233.
      Citations:    
    184. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e303-9. PMID: 26621648.
      Citations:    
    185. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e273-80. PMID: 26621644.
      Citations:    
    186. Link MS, Estes NA, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e339-42. PMID: 26621653.
      Citations:    
    187. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, Cooper LT, Link MS, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2362-2371. PMID: 26542657.
      Citations:    
    188. Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2356-2361. PMID: 26542659.
      Citations:    
    189. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2444-2446. PMID: 26542668.
      Citations:    
    190. Maron BJ, Harris KM, Thompson PD, Eichner ER, Steinberg MH. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e343-5. PMID: 26527715.
      Citations:    
    191. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2343-2349. PMID: 26542655.
      Citations:    
    192. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2424-2428. PMID: 26542662.
      Citations:    
    193. Mitten MJ, Zipes DP, Maron BJ, Bryant WJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2447-2450. PMID: 26542663.
      Citations:    
    194. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2398-2405. PMID: 26542664.
      Citations:    
    195. Link MS, Estes NAM, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2439-2443. PMID: 26542669.
      Citations:    
    196. Maron BJ, Rowin EJ, Casey SA, Lesser JR, Garberich RF, McGriff DM, Maron MS. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. Circulation. 2016 Jan 05; 133(1):62-73. PMID: 26518766.
      Citations:    
    197. Semsarian C, Ingles J, Maron MS, Maron BJ. Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy? J Am Coll Cardiol. 2015 Oct 20; 66(16):1846-1847. PMID: 26483114.
      Citations:    
    198. Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C, Pentiricci S, Poggio D, Grillo M, Amigoni P, Iascone M, Mortara A, Maron BJ, Senni M, Bruzzi P. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. J Am Coll Cardiol. 2015 Oct 13; 66(15):1687-96. PMID: 26449139.
      Citations:    
    199. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Nishimura RA, Ralph-Edwards A, Rakowski H, Sherrid MV, Swistel DG, Balaram S, Rastegar H, Rowin EJ, Smedira NG, Lytle BW, Desai MY, Lever HM. Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. J Am Coll Cardiol. 2015 Sep 15; 66(11):1307-1308. PMID: 26361164.
      Citations:    
    200. Maron BJ. Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years. Am J Cardiol. 2015 Nov 01; 116(9):1461-8. PMID: 26394831.
      Citations:    
    201. Maron MS, Maron BJ. Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy. Circulation. 2015 Jul 28; 132(4):292-8. PMID: 26216086.
      Citations:    
    202. Harris KM, Katsiyiannis WT, Maron BJ. What Constitutes an "Academic" Cardiology Practice? There Are New Models to Consider. Am J Cardiol. 2015 Sep 15; 116(6):995-6. PMID: 26228009.
      Citations:    
    203. Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS. Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Sep 01; 116(5):757-64. PMID: 26183790.
      Citations:    
    204. Sharkey SW, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ. Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy. Am J Cardiol. 2015 Sep 01; 116(5):765-72. PMID: 26144453.
      Citations:    
    205. Maron BJ, Rowin EJ, Kalra A, Lesser JR, Maron MS. Reply: To PMID 25759101. Am J Cardiol. 2015 Aug 01; 116(3):492-3. PMID: 26059868.
      Citations:    
    206. Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS. Hypertrophic Cardiomyopathy in?Adulthood Associated With Low?Cardiovascular Mortality With Contemporary Management Strategies. J Am Coll Cardiol. 2015 May 12; 65(18):1915-28. PMID: 25953744.
      Citations:    
    207. Chan RH, Maron BJ, Olivotto I, Assenza GE, Haas TS, Lesser JR, Gruner C, Crean AM, Rakowski H, Rowin E, Udelson J, Lombardi M, Tomberli B, Spirito P, Formisano F, Marra MP, Biagini E, Autore C, Manning WJ, Appelbaum E, Roberts WC, Basso C, Maron MS. Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Aug 01; 116(3):436-41. PMID: 26026863.
      Citations:    
    208. Maron BJ, Winkel BG, Tfelt-Hansen J. Cardiovascular screening for young athletes--reply. JAMA. 2015 Apr 28; 313(16):1674-5. PMID: 25919537.
      Citations:    
    209. Maron BJ, Link MS. Recurrent commotio cordis: D?j? vu. HeartRhythm Case Rep. 2015 Jul; 1(4):249-251. PMID: 28491560.
      Citations:    
    210. Maron BJ. Importance and feasibility of creating hypertrophic cardiomyopathy centers in developing countries: the experience in India. Am J Cardiol. 2015 Jul 15; 116(2):332-4. PMID: 25983127.
      Citations:    
    211. Maron BJ. Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy. Card Electrophysiol Clin. 2015 Jun; 7(2):165-71. PMID: 26002383.
      Citations:    
    212. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015 Mar 31; 65(12):1249-1254. PMID: 25814232.
      Citations:    
    213. Sharkey SW, McAllister N, Dassenko D, Lin D, Han K, Maron BJ. Evidence That High Catecholamine Levels Produced by Pheochromocytoma May be Responsible for Tako-Tsubo Cardiomyopathy. Am J Cardiol. 2015 Jun 01; 115(11):1615-8. PMID: 25851794.
      Citations:    
    214. Harris KM, Tung M, Haas TS, Maron BJ. Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes. J Am Coll Cardiol. 2015 Mar 03; 65(8):860-862. PMID: 25720631.
      Citations:    
    215. Maron BJ, Friedman RA, Caplan A. Ethics of preparticipation cardiovascular screening for athletes. Nat Rev Cardiol. 2015 Jun; 12(6):375-8. PMID: 25707388.
      Citations:    
    216. Maron BJ, Rakowski H. Dr. Douglas E. Wigle. Am J Cardiol. 2015 Feb 15; 115(4):553. PMID: 25802899.
      Citations:    
    217. Kalra A, Maron MS, Rowin EJ, Colgan TK, Lesser JR, Maron BJ. Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm. Am J Cardiol. 2015 May 01; 115(9):1318-9. PMID: 25759101.
      Citations:    
    218. Maron BJ, Winkel BG, Tfelt-Hansen J. Perspectives on cardiovascular screening. JAMA. 2015 Jan 06; 313(1):31-2. PMID: 25562261.
      Citations:    
    219. Maron BJ, Maron MS. The 20 advances that have defined contemporary hypertrophic cardiomyopathy. Trends Cardiovasc Med. 2015 Jan; 25(1):54-64. PMID: 25446045.
      Citations:    
    220. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more? J Am Coll Cardiol. 2014 Dec 16; 64(23):2562. PMID: 25500247.
      Citations:    
    221. Sharkey SW, Maron BJ. Left ventricular end diastolic pressure, suspected underlying hypertrophic cardiomyopathy, and takotsubo syndrome ? reply. Circ J. 2015; 79(1):222. PMID: 25421312.
      Citations:    
    222. Maron BJ, Weiner HL, Maron MS, Roberts WC. Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient. Am J Cardiol. 2015 Feb 01; 115(3):402-4. PMID: 25499402.
      Citations:    
    223. Maron BJ, Nishimura RA. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Circulation. 2014 Oct 28; 130(18):1617-24. PMID: 25462821.
      Citations:    
    224. Maron BJ, Nishimura RA. Revisiting arrhythmic risk after alcohol septal ablation: is the pendulum finally swinging?back to myectomy? JACC Heart Fail. 2014 Dec; 2(6):637-40. PMID: 25447347.
      Citations:    
    225. Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant. Circ Heart Fail. 2014 Nov; 7(6):967-75. PMID: 25239116.
      Citations: 22     Fields:    Translation:Humans
    226. Verdile L, Maron BJ, Pelliccia A, Spataro A, Santini M, Biffi A. Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities. Heart Rhythm. 2015 Jan; 12(1):78-85. PMID: 25239428.
      Citations:    
    227. Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2014 Oct 07; 64(14):1479-514. PMID: 25234655.
      Citations:    
    228. Maron BJ, Friedman R. To the editor--Participation screening for athletes. Heart Rhythm. 2014 Dec; 11(12):e199-200. PMID: 25172010.
      Citations:    
    229. Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2014 Nov 01; 114(9):1383-9. PMID: 25217454.
      Citations:    
    230. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014 Aug 05; 130(6):484-95. PMID: 25092278.
      Citations:    
    231. Sharkey SW, Maron BJ. Epidemiology and clinical profile of Takotsubo cardiomyopathy. Circ J. 2014; 78(9):2119-28. PMID: 25099475.
      Citations:    
    232. Maron BJ, Maron MS. The 25-year genetic era in hypertrophic cardiomyopathy: revisited. Circ Cardiovasc Genet. 2014 Aug; 7(4):401-4. PMID: 25140059.
      Citations:    
    233. Quattrini FM, Pelliccia A, Assorgi R, DiPaolo FM, Squeo MR, Culasso F, Castelli V, Link MS, Maron BJ. Benign clinical significance of J-wave pattern (early repolarization) in highly trained athletes. Heart Rhythm. 2014 Nov; 11(11):1974-82. PMID: 25092400.
      Citations:    
    234. Adalsteinsdottir B, Teekakirikul P, Maron BJ, Burke MA, Gudbjartsson DF, Holm H, Stefansson K, DePalma SR, Mazaika E, McDonough B, Danielsen R, Seidman JG, Seidman CE, Gunnarsson GT. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation. Circulation. 2014 Sep 30; 130(14):1158-67. PMID: 25078086.
      Citations:    
    235. Maron BJ, Kalra A. Hypertrophic cardiomyopathy in the developing world: focus on India. Eur Heart J. 2014 Sep 21; 35(36):2492-5. PMID: 25038775.
      Citations:    
    236. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014 Jul 08; 64(1):83-99. PMID: 24998133.
      Citations:    
    237. Biagini E, Olivotto I, Iascone M, Parodi MI, Girolami F, Frisso G, Autore C, Limongelli G, Cecconi M, Maron BJ, Maron MS, Rosmini S, Formisano F, Musumeci B, Cecchi F, Iacovoni A, Haas TS, Bacchi Reggiani ML, Ferrazzi P, Salvatore F, Spirito P, Rapezzi C. Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy. Am J Cardiol. 2014 Sep 01; 114(5):769-76. PMID: 25037680.
      Citations:    
    238. Spirito P, Autore C, Maron BJ. Reply: To PMID 24630786. Am J Cardiol. 2014 Aug 01; 114(3):501. PMID: 25017664.
      Citations:    
    239. Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Eur Heart J. 2014 Oct 14; 35(39):2706-13. PMID: 24810389.
      Citations:    
    240. Maron BJ, Haas TS, Goodman JS. Hypertrophic cardiomyopathy: one gene ? but many phenotypes. Am J Cardiol. 2014 May 15; 113(10):1772-3. PMID: 24792744.
      Citations:    
    241. Efthimiadis GK, Pitsis A, Pagourelias ED, Kamperidis V, Kelpis T, Meditskou S, Hadjimiltiades S, Ninios V, Mezilis N, Maron BJ, Styliadis IH. Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience. Hellenic J Cardiol. 2014 Mar-Apr; 55(2):132-8. PMID: 24681791.
      Citations:    
    242. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol. 2014 Apr 29; 63(16):1636-43. PMID: 24583295.
      Citations:    
    243. Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF. Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes. Int J Cardiol. 2014 May 15; 173(3):369-72. PMID: 24704402.
      Citations:    
    244. Spirito P, Autore C, Formisano F, Assenza GE, Biagini E, Haas TS, Bongioanni S, Semsarian C, Devoto E, Musumeci B, Lai F, Yeates L, Conte MR, Rapezzi C, Boni L, Maron BJ. Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors. Am J Cardiol. 2014 May 01; 113(9):1550-5. PMID: 24630786.
      Citations:    
    245. Maron BJ, Haas TS, Maron MS, Lesser JR, Browning JA, Chan RH, Olivotto I, Garberich RF, Schwartz RS. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. Am J Cardiol. 2014 Apr 15; 113(8):1394-400. PMID: 24589281.
      Citations:    
    246. Maron BJ. Recognition of hypertrophic cardiomyopathy as a contemporary, relatively common, and treatable disease (from the International Summit V). Am J Cardiol. 2014 Feb 15; 113(4):739-44. PMID: 24484864.
      Citations:    
    247. Maron BJ, Josephson ME. Long-term consequences of the right ventricular pacing mania of the 1990s for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2014 Jan 01; 113(1):191-2. PMID: 24239321.
      Citations:    
    248. Fox PR, Basso C, Thiene G, Maron BJ. Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease. Cardiovasc Pathol. 2014 Jan-Feb; 23(1):28-34. PMID: 24035181.
      Citations:    
    249. Maron BJ, Rastegar H, Udelson JE, Dearani JA, Maron MS. Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the Tufts initiative. Am J Cardiol. 2013 Nov 01; 112(9):1512-5. PMID: 24012037.
      Citations:    
    250. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NA, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation. 2013 May 21; 127(20):2021-30. PMID: 23690453.
      Citations:    
    251. Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Jul 30; 62(5):449-57. PMID: 23643593.
      Citations:    
    252. Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Apr 09; 61(14):1527-35. PMID: 23500286.
      Citations:    
    253. Sharkey SW, Lips DL, Pink VR, Maron BJ. Daughter-mother tako-tsubo cardiomyopathy. Am J Cardiol. 2013 Jul 01; 112(1):137-8. PMID: 23561588.
      Citations:    
    254. Rowin EJ, Maron BJ, Lesser JR, Rastegar H, Maron MS. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. Am J Cardiol. 2013 Jun 01; 111(11):1677-9. PMID: 23499271.
      Citations:    
    255. Sharkey SW, Maron BJ, Lesser JR. Authors' reply: takotsubo cardiomyopathy. Am J Cardiol. 2013 Feb 15; 111(4):628. PMID: 23375256.
      Citations:    
    256. Maron BJ, Maron MS. Hypertrophic cardiomyopathy in childhood: the gradient is not the disease. Excessive use of experimental invasive interventions. J Am Coll Cardiol. 2013 Jan 15; 61(2):210-1. PMID: 23273294.
      Citations:    
    257. Maron BJ, Harris KM, Haas TS, Eichner ER. Reply: To PMID 22809753. Am J Cardiol. 2013 Jan 01; 111(1):149. PMID: 23245840.
      Citations:    
    258. Rowin EJ, Maron BJ, Maron MS. Reply: To PMID 23245842. Am J Cardiol. 2013 Jan 01; 111(1):150-1. PMID: 23245841.
      Citations:    
    259. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, Garberich RF, Lesser JR, Appelbaum E, Manning WJ, Maron MS. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age. Circulation. 2013 Feb 05; 127(5):585-93. PMID: 23275385.
      Citations:    
    260. Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC. Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm. 2013 Mar; 10(3):374-7. PMID: 23207138.
      Citations:    
    261. Maron BJ, Haas TS, Ahluwalia A, Garberich RF, Estes NA, Link MS. Increasing survival rate from commotio cordis. Heart Rhythm. 2013 Feb; 10(2):219-23. PMID: 23107651.
      Citations:    
    262. Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients. Heart Rhythm. 2013 Feb; 10(2):214-8. PMID: 23041573.
      Citations:    
    263. Maron BJ, Braunwald E. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease. Circulation. 2012 Sep 25; 126(13):1640-4. PMID: 23008470.
      Citations:    
    264. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013 Jan 19; 381(9862):242-55. PMID: 22874472.
      Citations:    
    265. Harris KM, Haas TS, Eichner ER, Maron BJ. Sickle cell trait associated with sudden death in competitive athletes. Am J Cardiol. 2012 Oct 15; 110(8):1185-8. PMID: 22809753.
      Citations:    
    266. Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1027-32. PMID: 22809754.
      Citations:    
    267. Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012 Aug 21; 60(8):705-15. PMID: 22796258.
      Citations:    
    268. Sharkey SW, Lesser JR, Garberich RF, Pink VR, Maron MS, Maron BJ. Comparison of circadian rhythm patterns in Tako-tsubo cardiomyopathy versus ST-segment elevation myocardial infarction. Am J Cardiol. 2012 Sep 15; 110(6):795-9. PMID: 22651882.
      Citations:    
    269. Nistri S, Olivotto I, Maron MS, Ferrantini C, Coppini R, Grifoni C, Baldini K, Sgalambro A, Cecchi F, Maron BJ. ? Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012 Sep 01; 110(5):715-9. PMID: 22633205.
      Citations:    
    270. Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jul; 5(4):441-7. PMID: 22563033.
      Citations:    
    271. Maron BJ. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines. Prog Cardiovasc Dis. 2012 May-Jun; 54(6):523-8. PMID: 22687595.
      Citations:    
    272. Maron BJ. Counterpoint/Mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012 Nov; 9(11):1897. PMID: 22484648.
      Citations:    
    273. Braunwald E, Maron BJ. Eugene Braunwald, MD and the early years of hypertrophic cardiomyopathy: a conversation with Dr. Barry J. Maron. Am J Cardiol. 2012 Jun 01; 109(11):1539-47. PMID: 22425332.
      Citations:    
    274. Maron BJ. Counterpoint: Mandatory ECG screening of young competitive athletes. Heart Rhythm. 2012 Oct; 9(10):1646-9. PMID: 22426152.
      Citations:    
    275. Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy. Prog Cardiovasc Dis. 2012 Mar-Apr; 54(5):387-96. PMID: 22386289.
      Citations:    
    276. Maron BJ, Casey SA, Haas TS, Kitner CL, Garberich RF, Lesser JR. Hypertrophic cardiomyopathy with longevity to 90 years or older. Am J Cardiol. 2012 May 01; 109(9):1341-7. PMID: 22381158.
      Citations:    
    277. Maron BJ, Semsarian C. Prevention of sudden death for patients with cardiomyopathies another step forward. J Am Coll Cardiol. 2012 Jan 31; 59(5):501-2. PMID: 22281254.
      Citations:    
    278. Rowin EJ, Maron MS, Lesser JR, Maron BJ. CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2012 Jan; 5(1):119-22. PMID: 22239901.
      Citations:    
    279. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011 Dec; 142(6):1303-38. PMID: 22093712.
      Citations:    
    280. Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jan; 5(1):78-85. PMID: 22135401.
      Citations:    
    281. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011 Dec; 142(6):e153-203. PMID: 22093723.
      Citations:    
    282. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011 Dec 13; 58(25):2703-38. PMID: 22075468.
      Citations:    
    283. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011 Dec 13; 58(25):e212-60. PMID: 22075469.
      Citations:    
    284. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Dec 13; 124(24):2761-96. PMID: 22068435.
      Citations:    
    285. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Dec 13; 124(24):e783-831. PMID: 22068434.
      Citations:    
    286. Sharkey SW, Lesser JR, Maron BJ. Cardiology Patient Page. Takotsubo (stress) cardiomyopathy. Circulation. 2011 Nov 01; 124(18):e460-2. PMID: 22042929.
      Citations:    
    287. Maron BJ, Haas TS, Kitner C, Lesser JR. Onset of apical hypertrophic cardiomyopathy in adulthood. Am J Cardiol. 2011 Dec 15; 108(12):1783-7. PMID: 21958740.
      Citations:    
    288. Lakdawala NK, Thune JJ, Maron BJ, Cirino AL, Havndrup O, Bundgaard H, Christiansen M, Carlsen CM, Dorval JF, Kwong RY, Colan SD, K?ber LV, Ho CY. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol. 2011 Dec 01; 108(11):1606-13. PMID: 21943931.
      Citations:    
    289. Maron BJ, Maron MS, Semsarian C. Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. Heart Rhythm. 2012 Jan; 9(1):57-63. PMID: 21839045.
      Citations:    
    290. Maron BJ, Ahluwalia A, Haas TS, Semsarian C, Link MS, Estes NA. Global epidemiology and demographics of commotio cordis. Heart Rhythm. 2011 Dec; 8(12):1969-71. PMID: 21763255.
      Citations:    
    291. Thomas M, Haas TS, Doerer JJ, Hodges JS, Aicher BO, Garberich RF, Mueller FO, Cantu RC, Maron BJ. Epidemiology of sudden death in young, competitive athletes due to blunt trauma. Pediatrics. 2011 Jul; 128(1):e1-8. PMID: 21690117.
      Citations:    
    292. Maron BJ, Maron MS, Maron BA, Haas TS, Altman RK, Smalley SJ, Doerer JJ, Link MS, Mooney MR. Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011 Jun 14; 57(24):2454-6. PMID: 21640539.
      Citations:    
    293. Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011 Jul 05; 124(1):40-7. PMID: 21670234.
      Citations:    
    294. Maron BJ, Lindberg J, Haas TS, Kitner C, Schum K, Lesser JR, Maron MS. "Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years. Am J Cardiol. 2011 Jun 15; 107(12):1862-3. PMID: 21482415.
      Citations:    
    295. Sharkey SW, Lesser JR, Maron MS, Maron BJ. Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature. J Am Coll Cardiol. 2011 Mar 29; 57(13):1496-7. PMID: 21435521.
      Citations:    
    296. Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, Di Paolo FM, Spataro A, Delise P, Pelliccia A. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol. 2011 Mar 01; 107(5):697-703. PMID: 21316505.
      Citations:    
    297. Lin D, Lesser JR, Maron BJ. Coexistence of late gadolinium enhancement due to myocardial infarction and hypertrophic cardiomyopathy. Heart. 2011 May; 97(10):861-2. PMID: 21325656.
      Citations:    
    298. Maron BJ, Yacoub M, Dearani JA. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients. Eur Heart J. 2011 May; 32(9):1055-8. PMID: 21324934.
      Citations:    
    299. Chung WK, Kitner C, Maron BJ. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death. Cardiol Young. 2011 Jun; 21(3):345-8. PMID: 21262074.
      Citations:    
    300. Maron BJ, Yeates L, Semsarian C. Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy. Am J Cardiol. 2011 Feb 15; 107(4):604-8. PMID: 21185001.
      Citations:    
    301. Bos JM, Maron BJ, Ackerman MJ, Haas TS, Sorajja P, Nishimura RA, Gersh BJ, Ommen SR. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Nov 15; 106(10):1481-6. PMID: 21059440.
      Citations:    
    302. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology. 2011 Jan; 258(1):128-33. PMID: 21045187.
      Citations:    
    303. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ J. 2010 Nov; 74(11):2271-82. PMID: 20962423.
      Citations:    
    304. Maron BJ, Roberts WC, Ho CY, Kitner C, Haas TS, Wright GB, Moazami N, Feldman DS. Profound left ventricular remodeling associated with LAMP2 cardiomyopathy. Am J Cardiol. 2010 Oct 15; 106(8):1194-6. PMID: 20920663.
      Citations:    
    305. Nistri S, Olivotto I, Maron MS, Grifoni C, Baldini K, Baldi M, Sgalambro A, Cecchi F, Maron BJ. Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Nov 01; 106(9):1301-6. PMID: 21029828.
      Citations:    
    306. Maron BJ, Sherrid MV, Haas TS, Lindberg J, Kitner C, Lesser JR. Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall. Am J Cardiol. 2010 Sep 01; 106(5):750-2. PMID: 20723657.
      Citations:    
    307. Pelliccia A, Di Paolo FM, De Blasiis E, Quattrini FM, Pisicchio C, Guerra E, Culasso F, Maron BJ. Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes. Circulation. 2010 Aug 17; 122(7):698-706, 3 p following 706. PMID: 20679553.
      Citations:    
    308. Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, Udelson JE, O'Donnell C, Lesser JR, Manning WJ, Maron MS. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Jul 15; 106(2):261-7. PMID: 20599013.
      Citations:    
    309. Maron MS, Lesser JR, Maron BJ. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol. 2010 Jun 15; 105(12):1842-3. PMID: 20538141.
      Citations:    
    310. Maron BJ, Lindberg J, Haas TS, Kitner C, Lesser JR. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy. Am J Cardiol. 2010 Jun 01; 105(11):1643-4. PMID: 20494677.
      Citations:    
    311. Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J. 2010 Sep; 31(17):2111-23. PMID: 20513729.
      Citations:    
    312. Maron BJ, Lindberg J, Lesser JR. Ventricular septal crypt in hypertrophic cardiomyopathy. Eur Heart J. 2010 Aug; 31(15):1923. PMID: 20501477.
      Citations:    
    313. Maron BJ, Boren SD, Estes NA. Early descriptions of sudden cardiac death due to commotio cordis occurring in baseball. Heart Rhythm. 2010 Jul; 7(7):992-3. PMID: 20433944.
      Citations:    
    314. Pelliccia A, Kinoshita N, Pisicchio C, Quattrini F, Dipaolo FM, Ciardo R, Di Giacinto B, Guerra E, De Blasiis E, Casasco M, Culasso F, Maron BJ. Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol. 2010 Apr 13; 55(15):1619-25. PMID: 20378081.
      Citations:    
    315. Maron BJ. Can sudden cardiac death be prevented? Cardiovasc Pathol. 2010 Nov-Dec; 19(6):329-35. PMID: 20378375.
      Citations:    
    316. Harris KM, Henry JT, Rohman E, Haas TS, Maron BJ. Sudden death during the triathlon. JAMA. 2010 Apr 07; 303(13):1255-7. PMID: 20371783.
      Citations:    
    317. Maron BJ, Estes NA. Commotio cordis. N Engl J Med. 2010 Mar 11; 362(10):917-27. PMID: 20220186.
      Citations:    
    318. Maron BJ. National electrocardiography screening for competitive athletes: Feasible in the United States? Ann Intern Med. 2010 Mar 02; 152(5):324-6. PMID: 20194239.
      Citations:    
    319. Maron BJ. Sudden cardiac death in genetic heart diseases and the promise of prevention. Rev Esp Cardiol. 2010 Mar; 63(3):257-60. PMID: 20196984.
      Citations:    
    320. Maron BJ. The 2009 international hypertrophic cardiomyopathy summit. Am J Cardiol. 2010 Apr 15; 105(8):1164-8. PMID: 20381671.
      Citations:    
    321. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010 Jan 26; 55(4):333-41. PMID: 20117439.
      Citations:    
    322. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010 Jan 26; 121(3):445-56. PMID: 20100987.
      Citations:    
    323. Maron BJ. Dr. Gunnar Thor Gunnarsson and hypertrophic cardiomyopathy: what "giving back" means. Am J Cardiol. 2010 Jan 15; 105(2):277-8. PMID: 20108444.
      Citations:    
    324. Sherrid MV, Cotiga D, Hart D, Ehlert F, Haas TS, Shen WK, Link MS, Estes NA, Epstein AE, Semsarian C, Daubert JP, Winters SL, Giudici MC, Maron BJ. Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy. Am J Cardiol. 2009 Dec 15; 104(12):1722-6. PMID: 19962483.
      Citations:    
    325. Maron BJ, Lever H. In defense of antimicrobial prophylaxis for prevention of infective endocarditis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009 Dec 08; 54(24):2339-40; author reply 2340. PMID: 19958977.
      Citations:    
    326. Cecchi F, Olivotto I, Baldi M, Maron MS, Maron BJ. [Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Dec; 37(12):1069-73. PMID: 20193174.
      Citations:    
    327. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bj?rnstad HH, Carr? F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010 Jan; 31(2):243-59. PMID: 19933514.
      Citations:    
    328. Maron BJ. Sudden death in hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2009 Dec; 2(4):368-80. PMID: 20559995.
      Citations:    
    329. Maron BJ, Lesser JR, Schiller NB, Harris KM, Brown C, Rehm HL. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA. 2009 Oct 21; 302(15):1681-4. PMID: 19843903.
      Citations:    
    330. Knickelbine T, Lesser JR, Haas TS, Brandenburg ER, Gleason-Han BK, Flygenring B, Longe TF, Schwartz RS, Maron BJ. Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography. JACC Cardiovasc Imaging. 2009 Sep; 2(9):1085-92. PMID: 19761987.
      Citations:    
    331. Maron BJ. Hypertrophic cardiomyopathy centers. Am J Cardiol. 2009 Oct 15; 104(8):1158-9. PMID: 19801041.
      Citations:    
    332. Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, Camici PG. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009 Aug 25; 54(9):866-75. PMID: 19695469.
      Citations:    
    333. Maron BJ, Doerer JJ, Haas TS, Estes NA, Hodges JS, Link MS. Commotio cordis and the epidemiology of sudden death in competitive lacrosse. Pediatrics. 2009 Sep; 124(3):966-71. PMID: 19706581.
      Citations:    
    334. Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009 Jul 14; 54(3):191-200. PMID: 19589431.
      Citations:    
    335. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009 Jul 14; 54(3):220-8. PMID: 19589434.
      Citations:    
    336. Madias C, Maron BJ, Alsheikh-Ali AA, Rajab M, Estes NA, Link MS. Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation. Heart Rhythm. 2009 Oct; 6(10):1495-500. PMID: 19968931.
      Citations:    
    337. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, K?ber L. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2009 Aug; 2(4):314-21. PMID: 20031602.
      Citations:    
    338. Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol. 2009 Jul 15; 104(2):276-80. PMID: 19576360.
      Citations:    
    339. Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J. 2009 Jul; 30(13):1627-34. PMID: 19406869.
      Citations:    
    340. Olivotto I, DiDonna P, Baldi M, Sgalambro A, Maron BJ, Cecchi F. [Atrial fibrillation in hypertrophic cardiomyopathy: determinants, clinical course and management]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr; 37(4):303-7. PMID: 19791463.
      Citations:    
    341. Maron BJ, Spirito P. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr; 37(4):297-302. PMID: 19791462.
      Citations:    
    342. Spirito P, Maron BJ. [Risk stratification for sudden death in hypertrophic cardiomyopathy]. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr; 37(4):294-7. PMID: 19791461.
      Citations:    
    343. Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP, Ho CY, Seidman J, Seidman CE. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009 Mar 25; 301(12):1253-9. PMID: 19318653.
      Citations:    
    344. Spirito P, Autore C, Rapezzi C, Bernab? P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barill? CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009 Apr 07; 119(13):1703-10. PMID: 19307481.
      Citations:    
    345. Maron BJ, Haas TS, Shannon KM, Almquist AK, Hodges JS. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm. 2009 Jul; 6(7):993-7. PMID: 19497790.
      Citations:    
    346. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009 Mar 03; 119(8):1085-92. PMID: 19221222.
      Citations:    
    347. Maron BJ, Semsarian C, Shen WK, Link MS, Epstein AE, Estes NA, Almquist A, Giudici MC, Haas TS, Hodges JS, Spirito P. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2009 May; 6(5):599-602. PMID: 19332391.
      Citations:    
    348. Maron BJ, Seidman CE, Ackerman MJ, Towbin JA, Maron MS, Ommen SR, Nishimura RA, Gersh BJ. How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ Cardiovasc Genet. 2009 Feb; 2(1):81-5; discussion 86. PMID: 20031569.
      Citations:    
    349. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008 Dec 09; 52(24):1990-6. PMID: 19055990.
      Citations:    
    350. Lim KK, Maron BJ, Knight BP. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm. J Cardiovasc Electrophysiol. 2009 Apr; 20(4):445-7. PMID: 19054248.
      Citations:    
    351. Maron BJ, Bonow RO, Salberg L, Roberts WC, Braunwald E. The first patient clinically diagnosed with hypertrophic cardiomyopathy. Am J Cardiol. 2008 Nov 15; 102(10):1418-20. PMID: 18993166.
      Citations:    
    352. Sharkey SW, Maron BJ, Nelson P, Parpart M, Maron MS, Bristow MR. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol. 2009 Feb; 53(1):53-7. PMID: 19167638.
      Citations:    
    353. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Heart Rhythm. 2008 Oct; 5(10):e1-21. PMID: 18929319.
      Citations:    
    354. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008 Sep 30; 118(14):1497-1518. PMID: 18833586.
      Citations:    
    355. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol. 2008 Sep 30; 52(14):1179-99. PMID: 18804749.
      Citations:    
    356. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008 Oct 07; 118(15):1541-9. PMID: 18809796.
      Citations:    
    357. Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A. Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm. 2008 Nov; 5(11):1517-22. PMID: 18984525.
      Citations:    
    358. Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Aug 12; 52(7):559-66. PMID: 18687251.
      Citations:    
    359. Madias C, Maron BJ, Supron S, Estes NA, Link MS. Cell membrane stretch and chest blow-induced ventricular fibrillation: commotio cordis. J Cardiovasc Electrophysiol. 2008 Dec; 19(12):1304-9. PMID: 18691236.
      Citations:    
    360. Link MS, Bir C, Dau N, Madias C, Estes NA, Maron BJ. Protecting our children from the consequences of chest blows on the playing field: a time for science over marketing. Pediatrics. 2008 Aug; 122(2):437-9. PMID: 18676560.
      Citations:    
    361. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2008 Sep; 1(3):184-91. PMID: 19808288.
      Citations:    
    362. Magalski A, Maron BJ, Main ML, McCoy M, Florez A, Reid KJ, Epps HW, Bates J, Browne JE. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol. 2008 Jun 10; 51(23):2250-5. PMID: 18534272.
      Citations:    
    363. Maron BJ. The 2006 American Heart Association classification of cardiomyopathies is the gold standard. Circ Heart Fail. 2008 May; 1(1):72-5; discussion 76. PMID: 19808273.
      Citations:    
    364. Biffi A, Maron BJ, Di Giacinto B, Porcacchia P, Verdile L, Fernando F, Spataro A, Culasso F, Casasco M, Pelliccia A. Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. Am J Cardiol. 2008 Jun 15; 101(12):1792-5. PMID: 18549861.
      Citations:    
    365. Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol. 2008 Jun 15; 101(12):1723-8. PMID: 18549847.
      Citations:    
    366. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008 Apr 08; 51(14):1369-74. PMID: 18387438.
      Citations:    
    367. Maron BJ, Spirito P. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008 Oct; 19(10):1118-26. PMID: 18384577.
      Citations:    
    368. Maron BJ, Ommen SR, Nishimura RA, Dearani JA. Myths about surgical myectomy: rumors of its death have been greatly exaggerated. Am J Cardiol. 2008 Mar 15; 101(6):887-9. PMID: 18328859.
      Citations:    
    369. Maron BJ, Zipes DP. It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports. Heart Rhythm. 2008 Jun; 5(6):864-6. PMID: 18463001.
      Citations:    
    370. Maron BJ. Medical data, the media, and distortion of the facts in the internet era. Am J Cardiol. 2008 Mar 15; 101(6):890-1. PMID: 18328860.
      Citations:    
    371. Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, De Luca R, Spataro A, Biffi A, Thiene G, Maron BJ. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008 Jan 10; 358(2):152-61. PMID: 18184960.
      Citations:    
    372. Maron BJ, Maron MS, Lesser JR, Hauser RG, Haas TS, Harrigan CJ, Appelbaum E, Main ML, Roberts WC. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol. 2008 Feb 15; 101(4):544-7. PMID: 18312775.
      Citations:    
    373. Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2008 Mar 01; 101(5):668-73. PMID: 18308018.
      Citations:    
    374. Friedewald VE, Maron BJ, Roberts WC. The editor's roundtable: sudden cardiac death in athletes. Am J Cardiol. 2007 Nov 01; 100(9):1451-9. PMID: 17950807.
      Citations:    
    375. Glover DW, Glover DW, Maron BJ. Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol. 2007 Dec 01; 100(11):1709-12. PMID: 18036373.
      Citations:    
    376. Madias C, Maron BJ, Alsheikh-Ali AA, Estes Iii NA, Link MS. Commotio cordis. Indian Pacing Electrophysiol J. 2007 Oct 22; 7(4):235-45. PMID: 17957272.
      Citations:    
    377. Almquist AK, Hanna CA, Haas TS, Maron BJ. Significance of appropriate defibrillator shock 3 hours and 20 minutes following implantation in a patient with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008 Mar; 19(3):319-22. PMID: 17764447.
      Citations:    
    378. Olivotto I, Ommen SR, Maron MS, Cecchi F, Maron BJ. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? J Am Coll Cardiol. 2007 Aug 28; 50(9):831-4. PMID: 17719467.
      Citations:    
    379. Maron BJ. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiol Clin. 2007 Aug; 25(3):399-414, vi. PMID: 17961794.
      Citations:    
    380. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007 Jul 25; 298(4):405-12. PMID: 17652294.
      Citations:    
    381. Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation. 2007 Jul 10; 116(2):196-206; discussion 206. PMID: 17620519.
      Citations:    
    382. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Prehosp Emerg Care. 2007 Jul-Sep; 11(3):253-71. PMID: 17613898.
      Citations:    
    383. Maron BA, Haas TS, Maron BJ. Sudden death from collapsing sand holes. N Engl J Med. 2007 Jun 21; 356(25):2655-6. PMID: 17582084.
      Citations:    
    384. Maron BJ, Haas TS, Lesser JR. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy. Circulation. 2007 Jun 19; 115(24):e627-8. PMID: 17576874.
      Citations:    
    385. Maron BJ, Hauser RG. Perspectives on the failure of pharmaceutical and medical device industries to fully protect public health interests. Am J Cardiol. 2007 Jul 01; 100(1):147-51. PMID: 17599459.
      Citations:    
    386. Maron BJ. Hypertrophic cardiomyopathy in China. Am J Cardiol. 2007 Jul 01; 100(1):145-6. PMID: 17599458.
      Citations:    
    387. Maron BJ, Basso C. Myocarditis in hypertrophic cardiomyopathy. Eur Heart J. 2007 Jul; 28(13):1663-4; author reply 1664. PMID: 17483536.
      Citations:    
    388. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation. 2007 May 01; 115(17):2358-68. PMID: 17468391.
      Citations:    
    389. Adabag AS, Maron BJ. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol. 2007 Apr; 12(2):171-80. PMID: 17593187.
      Citations:    
    390. Maron BJ, Roberts WC. Barry Joel Maron, MD: a conversation with the Editor. Interview by William Clifford Roberts. Am J Cardiol. 2007 May 01; 99(9):1334-49. PMID: 17478169.
      Citations:    
    391. Maron BJ. Does preparticipation cardiovascular screening of athletes save lives? Nat Clin Pract Cardiovasc Med. 2007 May; 4(5):240-1. PMID: 17356518.
      Citations:    
    392. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007 Mar 27; 115(12):1643-455. PMID: 17353433.
      Citations:    
    393. Cha YM, Gersh BJ, Maron BJ, Boriani G, Spirito P, Hodge DO, Weivoda PL, Trusty JM, Friedman PA, Hammill SC, Rea RF, Shen WK. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2007 May; 18(5):483-7. PMID: 17343723.
      Citations:    
    394. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Clin J Sport Med. 2007 Mar; 17(2):87-103. PMID: 17414476.
      Citations:    
    395. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Heart Rhythm. 2007 Apr; 4(4):549-65. PMID: 17399652.
      Citations:    
    396. Sharkey SW, Lesser JR, Maron MS, Maron BJ. Stress cardiomyopathy. J Am Coll Cardiol. 2007 Feb 27; 49(8):921; author reply 921-2. PMID: 17320752.
      Citations:    
    397. Doerer JJ, Haas TS, Estes NA, Link MS, Maron BJ. Evaluation of chest barriers for protection against sudden death due to commotio cordis. Am J Cardiol. 2007 Mar 15; 99(6):857-9. PMID: 17350382.
      Citations:    
    398. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Jan 23; 49(3):350-7. PMID: 17239717.
      Citations:    
    399. Madias C, Maron BJ, Weinstock J, Estes NA, Link MS. Commotio cordis--sudden cardiac death with chest wall impact. J Cardiovasc Electrophysiol. 2007 Jan; 18(1):115-22. PMID: 17229310.
      Citations:    
    400. Maron BA, Fein S, Maron BJ, Hillel AT, El Baghdadi MM, Rodenhauser P. Ability of prospective assessment of personality profiles to predict the practice specialty of medical students. Proc (Bayl Univ Med Cent). 2007 Jan; 20(1):22-6. PMID: 17256038.
      Citations:    
    401. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. J Athl Train. 2007 Jan-Mar; 42(1):143-58. PMID: 17597956.
      Citations:    
    402. Stout CW, Maron BJ, Vanderbrink BA, Estes NA, Link MS. Importance of the autonomic nervous system in an experimental model of commotio cordis. Med Sci Monit. 2007 Jan; 13(1):BR11-5. PMID: 17179901.
      Citations:    
    403. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006 Nov 21; 114(21):2232-9. PMID: 17088454.
      Citations:    
    404. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol. 2006 Dec 01; 98(11):1507-11. PMID: 17126660.
      Citations:    
    405. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006 Oct 10; 114(15):1633-44. PMID: 17030703.
      Citations:    
    406. Harris KM, Sponsel A, Hutter AM, Maron BJ. Brief communication: Cardiovascular screening practices of major North American professional sports teams. Ann Intern Med. 2006 Oct 03; 145(7):507-11. PMID: 17015868.
      Citations:    
    407. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, Conte MR, Casazza F, Galderisi M, Maron BJ, Cecchi F. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006 Oct 01; 98(7):960-5. PMID: 16996883.
      Citations:    
    408. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006 Jul 18; 114(3):216-25. PMID: 16831987.
      Citations:    
    409. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, Spataro A, Biffi A, Granata M, Maron BJ. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006 Sep; 27(18):2196-200. PMID: 16831826.
      Citations:    
    410. Maron BJ, Olivotto I, Maron MS. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators? Eur Heart J. 2006 Aug; 27(16):1895-7. PMID: 16818455.
      Citations:    
    411. Maron BJ, Doerer JJ, Haas TS, Estes NA, Link MS. Historical observation on commotio cordis. Heart Rhythm. 2006 May; 3(5):605-6. PMID: 16648070.
      Citations:    
    412. Weinstock J, Maron BJ, Song C, Mane PP, Estes NA, Link MS. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics. 2006 Apr; 117(4):e656-62. PMID: 16510614.
      Citations:    
    413. Zenovich AG, Lesser JR, Hanna CA, Maron BJ. Identical twins with hypertrophic cardiomyopathy and apical aneurysm. Am J Cardiol. 2006 Apr 01; 97(7):1109. PMID: 16563928.
      Citations:    
    414. Salib EA, Cyran SE, Cilley RE, Maron BJ, Thomas NJ. Efficacy of bystander cardiopulmonary resuscitation and out-of-hospital automated external defibrillation as life-saving therapy in commotio cordis. J Pediatr. 2005 Dec; 147(6):863-6. PMID: 16356450.
      Citations:    
    415. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, Barr S, Karim A, Olson TM, Kamisago M, Seidman JG, Seidman CE. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005 Nov 01; 112(18):2805-11. PMID: 16267253.
      Citations:    
    416. Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol. 2005 Oct 04; 46(7):1373-4. PMID: 16198859.
      Citations:    
    417. Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W. Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):67-83. PMID: 16274418.
      Citations:    
    418. Hauser RG, Maron BJ. Lessons from the failure and recall of an implantable cardioverter-defibrillator. Circulation. 2005 Sep 27; 112(13):2040-2. PMID: 16172264.
      Citations:    
    419. Maron BJ, Wentzel DC, Zenovich AG, Estes NA, Link MS. Death in a young athlete due to commotio cordis despite prompt external defibrillation. Heart Rhythm. 2005 Sep; 2(9):991-3. PMID: 16171756.
      Citations:    
    420. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, Roselli A, Caselli S, Culasso F. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005 Aug 16; 46(4):690-6. PMID: 16098437.
      Citations:    
    421. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005 Aug 09; 112(6):855-61. PMID: 16087809.
      Citations:    
    422. Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Aug 02; 46(3):480-7. PMID: 16053962.
      Citations:    
    423. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Aug 02; 46(3):470-6. PMID: 16053960.
      Citations:    
    424. Almquist AK, Montgomery JV, Haas TS, Maron BJ. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm. 2005 Aug; 2(8):814-9. PMID: 16051115.
      Citations:    
    425. Maron BJ. LQTS and SIDS linkage: clarifying the record. Am J Cardiol. 2005 Jul 15; 96(2):323. PMID: 16018868.
      Citations:    
    426. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2005 Jul 15; 96(2):270-5. PMID: 16018856.
      Citations:    
    427. Gornick CC, Hauser RG, Almquist AK, Maron BJ. Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy. Heart Rhythm. 2005 Jul; 2(7):681-3. PMID: 15992719.
      Citations:    
    428. Maron MS, Zenovich AG, Casey SA, Link MS, Udelson JE, Aeppli DM, Maron BJ. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy. Am J Cardiol. 2005 Jun 01; 95(11):1329-33. PMID: 15904638.
      Citations:    
    429. Mitten MJ, Maron BJ, Zipes DP. Task Force 12: legal aspects of the 36th Bethesda Conference recommendations. J Am Coll Cardiol. 2005 Apr 19; 45(8):1373-5. PMID: 15837292.
      Citations:    
    430. Maron BJ, Estes NA, Link MS. Task Force 11: commotio cordis. J Am Coll Cardiol. 2005 Apr 19; 45(8):1371-3. PMID: 15837291.
      Citations:    
    431. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005 Apr 19; 45(8):1340-5. PMID: 15837284.
      Citations:    
    432. Maron BJ, Douglas PS, Graham TP, Nishimura RA, Thompson PD. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol. 2005 Apr 19; 45(8):1322-6. PMID: 15837281.
      Citations:    
    433. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Apr 19; 45(8):1251-8. PMID: 15837258.
      Citations:    
    434. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol. 2005 Apr 19; 45(8):1318-21. PMID: 15837280.
      Citations:    
    435. Garan AR, Maron BJ, Wang PJ, Estes NA, Link MS. Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis). J Cardiovasc Electrophysiol. 2005 Apr; 16(4):433-8. PMID: 15828890.
      Citations:    
    436. Link MS, Maron BJ. Sudden cardiac death caused by innocent chest wall blows. Ital Heart J. 2005 Apr; 6(4):281-3. PMID: 15902925.
      Citations:    
    437. Maron BJ. Ten common questions about hypertrophic cardiomyopathy...and misconceptions. Cardiol Rev. 2005 Mar-Apr; 13(2):59-60. PMID: 15705254.
      Citations:    
    438. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Mar 01; 45(5):697-704. PMID: 15734613.
      Citations:    
    439. Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005 Feb 01; 111(4):472-9. PMID: 15687136.
      Citations:    
    440. Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005 Jan 27; 352(4):362-72. PMID: 15673802.
      Citations:    
    441. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004 Dec 07; 44(11):2125-32. PMID: 15582308.
      Citations:    
    442. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004 Nov 16; 44(10):2044-53. PMID: 15542290.
      Citations:    
    443. Zenovich AG, Lesser JR, Casey SA, Maron BJ. Images in cardiovascular medicine. Hypertrophic cardiomyopathy with apical aneurysm. Circulation. 2004 Oct 19; 110(16):e450. PMID: 15492326.
      Citations:    
    444. Boriani G, Maron BJ, Shen WK, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation. 2004 Oct 12; 110(15):e438-42. PMID: 15477422.
      Citations:    
    445. Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am. 2004 Oct; 51(5):1305-46. PMID: 15331286.
      Citations:    
    446. Biffi A, Maron BJ, Verdile L, Fernando F, Spataro A, Marcello G, Ciardo R, Ammirati F, Colivicchi F, Pelliccia A. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2004 Sep 01; 44(5):1053-8. PMID: 15337218.
      Citations:    
    447. Maron BJ, Spirito P, Roman MJ, Paranicas M, Okin PM, Best LG, Lee ET, Devereux RB. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol. 2004 Jun 15; 93(12):1510-4. PMID: 15194022.
      Citations:    
    448. Maron BJ, Chaitman BR, Ackerman MJ, Bay?s de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA, Ara?jo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004 Jun 08; 109(22):2807-16. PMID: 15184297.
      Citations:    
    449. Basso C, Fox PR, Meurs KM, Towbin JA, Spier AW, Calabrese F, Maron BJ, Thiene G. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation. 2004 Mar 09; 109(9):1180-5. PMID: 14993138.
      Citations:    
    450. Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, Cohn JN. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation. 2004 Mar 02; 109(8):984-9. PMID: 14967727.
      Citations:    
    451. Sarto P, Merlo L, Noventa D, Basso C, Pelliccia A, Maron BJ. Electrocardiographic changes associated with training and discontinuation of training in an athlete with hypertrophic cardiomyopathy. Am J Cardiol. 2004 Feb 15; 93(4):518-9. PMID: 14969643.
      Citations:    
    452. Maron BJ, Barry JA, Poole RS. Pilots, hypertrophic cardiomyopathy, and issues of aviation and public safety. Am J Cardiol. 2004 Feb 15; 93(4):441-4. PMID: 14969618.
      Citations:    
    453. Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 03; 109(4):452-6. PMID: 14757682.
      Citations:    
    454. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004 Feb; 127(2):481-9. PMID: 14762358.
      Citations:    
    455. Maron BJ. Hypertrophic cardiomyopathy: an important global disease. Am J Med. 2004 Jan 01; 116(1):63-5. PMID: 14706671.
      Citations:    
    456. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003 Nov 15; 92(10):1183-6. PMID: 14609593.
      Citations:    
    457. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 05; 42(9):1687-713. PMID: 14607462.
      Citations:    
    458. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003 Nov; 24(21):1965-91. PMID: 14585256.
      Citations:    
    459. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003 Sep 11; 349(11):1064-75. PMID: 12968091.
      Citations:    
    460. Maron BJ, Casey SA, Hauser RG, Aeppli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 2003 Sep 03; 42(5):882-8. PMID: 12957437.
      Citations:    
    461. Maron BJ, Poliac LC, Ashare AB, Hall WA. Sudden death due to neck blows among amateur hockey players. JAMA. 2003 Aug 06; 290(5):599-601. PMID: 12902362.
      Citations:    
    462. Maron BJ, Estes NA, Maron MS, Almquist AK, Link MS, Udelson JE. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 2003 Jun 17; 107(23):2872-5. PMID: 12814983.
      Citations:    
    463. Maron BJ, Casey SA, Hurrell DG, Aeppli DM. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol. 2003 May 15; 91(10):1195-8. PMID: 12745102.
      Citations:    
    464. Nistri S, Thiene G, Basso C, Corrado D, Vitolo A, Maron BJ. Screening for hypertrophic cardiomyopathy in a young male military population. Am J Cardiol. 2003 Apr 15; 91(8):1021-3, A8. PMID: 12686356.
      Citations:    
    465. Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, Sherrid MV. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003 Mar 19; 41(6):974-80. PMID: 12651044.
      Citations:    
    466. Maron BJ, Piccininno M, Casey SA, Bernab? P, Spirito P. Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy. Am J Cardiol. 2003 Mar 01; 91(5):626-8. PMID: 12615280.
      Citations:    
    467. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003 Jan 23; 348(4):295-303. PMID: 12540642.
      Citations:    
    468. Link MS, Maron BJ, Stickney RE, Vanderbrink BA, Zhu W, Pandian NG, Wang PJ, Estes NA. Automated external defibrillator arrhythmia detection in a model of cardiac arrest due to commotio cordis. J Cardiovasc Electrophysiol. 2003 Jan; 14(1):83-7. PMID: 12625616.
      Citations:    
    469. Link MS, Maron BJ, Wang PJ, VanderBrink BA, Zhu W, Estes NA. Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis). J Am Coll Cardiol. 2003 Jan 01; 41(1):99-104. PMID: 12570951.
      Citations:    
    470. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003 Jan; 24(1):13-5. PMID: 12559931.
      Citations:    
    471. Maron BJ. Cardiology patient pages. Hypertrophic cardiomyopathy. Circulation. 2002 Nov 05; 106(19):2419-21. PMID: 12417536.
      Citations:    
    472. Strasburger JF, Maron BJ. Images in clinical medicine. Commotio cordis. N Engl J Med. 2002 Oct 17; 347(16):1248. PMID: 12393822.
      Citations:    
    473. Sharma S, Maron BJ, Whyte G, Firoozi S, Elliott PM, McKenna WJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002 Oct 16; 40(8):1431-6. PMID: 12392833.
      Citations:    
    474. Ratliff NB, Harris KM, Smith SA, Tankh-Johnson M, Gornick CC, Maron BJ. Cardiac arrest in a young marathon runner. Lancet. 2002 Aug 17; 360(9332):542. PMID: 12241659.
      Citations:    
    475. Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S, Santini M, Maron BJ. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002 Aug 07; 40(3):446-52. PMID: 12142109.
      Citations:    
    476. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002 Jun 25; 105(25):2992-7. PMID: 12081993.
      Citations:    
    477. Maron BJ, Casey SA, Almquist AK. Images in cardiovascular medicine. Hypertrophic cardiomyopathy in monozygotic twins. Circulation. 2002 May 07; 105(18):2229. PMID: 11994260.
      Citations:    
    478. Maron BJ. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Cardiol Rev. 2002 May-Jun; 10(3):173-81. PMID: 12047795.
      Citations:    
    479. Link MS, Maron BJ, Wang PJ, Pandian NG, VanderBrink BA, Estes NA. Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics. 2002 May; 109(5):873-7. PMID: 11986449.
      Citations:    
    480. Maron BJ, Sharkey SW, Casey SA, Lawler CM. Two husbands--one disease: the broad clinical spectrum of hypertrophic cardiomyopathy. Am J Cardiol. 2002 Apr 01; 89(7):899-900. PMID: 11909588.
      Citations:    
    481. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002 Mar 13; 287(10):1308-20. PMID: 11886323.
      Citations:    
    482. Maron BJ, Gohman TE, Kyle SB, Estes NA, Link MS. Clinical profile and spectrum of commotio cordis. JAMA. 2002 Mar 06; 287(9):1142-6. PMID: 11879111.
      Citations:    
    483. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation. 2002 Feb 26; 105(8):944-9. PMID: 11864923.
      Citations:    
    484. Semsarian C, Maron BJ. Sudden cardiac death in the young. Med J Aust. 2002 Feb 18; 176(4):148-9. PMID: 11913912.
      Citations:    
    485. Maron BJ. The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification. Card Electrophysiol Rev. 2002 Feb; 6(1-2):100-3. PMID: 11984027.
      Citations:    
    486. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, Casey SA, Gohman TE, Bongioanni S, Spirito P. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002 Jan 16; 39(2):301-7. PMID: 11788223.
      Citations:    
    487. Maron BJ, Mitten MJ, Greene Burnett C. Criminal consequences of commotio cordis. Am J Cardiol. 2002 Jan 15; 89(2):210-3. PMID: 11792344.
      Citations:    
    488. Maron BJ. Hypertrophic cardiomyopathy: practical steps for preventing sudden death. Phys Sportsmed. 2002 Jan; 30(1):19-24. PMID: 20086497.
      Citations:    
    Maron's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (627)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _